Menu

Roche Diabetes Care at the hybrid EASD 2024 meeting

Monday, September 9, 2024 - Friday, September 13, 2024

Order Publications and Solution Brochures
 

Exhibit info

We look forward to welcoming you to our booth no. B.04 and talk with you about our new Accu-Chek SmartGuide CGM solution!
For those who will join the EASD conference online, please make sure to visit our virtual Showroom, where you find more information on our new Accu-Chek SmartGuide CGM solution! Feel free to contact us for more information and visit us on LinkedIn .

Location

IFEMA congress center
North Entrance, Avda. del Partenon 5
28042 Madrid, Spain

and online

Exhibition

Exhibition Hall no. 10, booth no. B.04

Opening hours

Tuesday, September 10: 9:00 – 16:30
Wednesday, September 11: 9:30 – 16:30
Thursday, September 12: 9:30 – 16:30

  Order now

Receive Roche Diabetes Care solutions brochures and publications links via email!

Order now
 

Publications

Automated Bolus Advisor

Use of an Automated Bolus Calculator in MDI-Treated Type 1 Diabetes - The BolusCal Study, a randomized controlled pilot study

(Schmidt et al. Diabetes Care, 2012 May;35(5):984-90.)

Read publication

Systematic Improvement of a Bolus Calculator that is On The Market: A User-Centric Approach

(Valerie Eichinger et al. Journal of Diabetes Science and Technology (EPub), July 23, 2024)

Read publication

Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial

(Ziegler et al. Diabetes Care. 2013 Nov; 36(11):3613-9.)

Read publication

SMBG – System Performance

System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose According to DIN EN ISO 15197

(Freckmann et al. J Diabetes Sci Technol. 2012 Sep 1;6(5):1060-75.)

Read publication

System accuracy evaluation of 18 CE marked current generation blood glucose monitoring systems based on EN ISO 15197:2015

(Pleus et al. BMJ Open Diabetes Res Care. 2020, 8(1): e001067)

Read publication

Structured Testing and Pattern Analysis

Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study

(Mora et al. Diabetes Technol Ther. 2017 Dec 1;19(12):715-22.)

Read publication

Evaluation of a new digital automated glycemic pattern detection tool

(Comellas et al. Diabetes Techno Ther. 2017 Nov 1;19(11):633-40)

Read publication

Use of Diabetes Data Management Software Reports by Health Care Providers, Patients With Diabetes, and Caregivers Improves Accuracy and Efficiency of Data Analysis and Interpretation Compared With Traditional Logbook Data: First Results of the Accu-Chek Connect Reports Utility and Efficiency Study (ACCRUES)

(Hinnen et al. J Diabetes Sci Technol. 2015 Mar:9(2):293-301.)

Read publication

What Do We Need beyond Hemoglobin A1c to Get the Complete Picture of glycemia in people with diabetes?

(Hinzmann et al. Int. J Med Sci. 2012;9(8):665-81.)

Read publication

CGM

A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II

(Christiansen et al. Diabetes Technol. Ther. 2018 Jan 30 (Epub))

Read publication

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial

(Kropff et al. Diabetes Care 2017 Jan:40(1):63-68.)

Read publication

Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space

(Heinemann et al. J Diabetes Sci Technol. 2019 Jun (Epub))

Read publication

Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice

(Johnson et al. J Diabetes Sci Technol. 2019 Jun:21(S2):S217-5225.)

Read publication

Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space

(Heinemann et al. J Diabetes Sci Technol. 2020 Jan;14(1):135–150.)

Read publication

Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM

(Ziegler et al. J Diabetes Sci Technol. 2021 May;15(3):684-694.)

Read publication

Standardization process of continuous glucose monitoring: Traceability and performance

(Freckmann et al. Clin. Chim. Acta. 2021 Apr;515:5-12.)

Read publication

Predicting Glucose Values: A New Era for Continuous Glucose Monitoring

(Bernhard Kulzer, Lutz Heinemann JDST, Volume 18, issue 5, August 19, 2024)

Read publication

Concept and Implementation of a Novel Continuous Glucose Monitoring Solution with Glucose Predictions on Board

(Timor Glatzer et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

Enhancing the Capabilities of Continuous Glucose Monitoring with a Predictive App

(Pau Herrero et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

Clinical Usage and Potential Benefits of a Continuous Glucose Monitoring Predict App

(Timor Glatzer et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring

(Bernhard Kulzer et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

Performance of a Novel Continuous Glucose Monitoring Device in People with Diabetes

(Julia K. Mader et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

Fear of Hypoglycemia and Diabetes Distress: Expected Reduction by Glucose Prediction

(Dominic Ehrmann et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

The Promise of Hypoglycemia Risk Prediction

(Oliver Schnell et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

Characteristics of Nocturnal Hypoglycaemic Events and Their Impact on Glycaemia

(Manuel Eichenlaub et al. JDST, Volume 18, issue 5, August 19, 2024)

Read publication

CSII

Boluses in insulin therapy: A Commentary

(Ziegler et al. J Diabetes Technol. 2017;11(1):165-71.)

Read publication

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study

(Steineck et al. BMJ 2015; 350: h3234.)

Read publication

Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?

(Barnard et al. J Diabetes Sci Technol. 2018 Nov;12(6):1223-1226)

Read publication

Patch Pumps: Are They All the Same?

(Heinemann et al. J Diabetes Sci Technol. 2019 Jan:13(1):34-40.)

Read publication

Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps

(Kamecke et al. J Diabetes Sci Technol. 2018; ePub)

Read publication

Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates

(Freckmann et al. J Diabetes Sci Technol. 2018;12(3):608-613)

Read publication

Continuous subcutaneous insulin infusion: Special needs for children

(Adolfsson et al. Pediatr. Diabetes 2017 Jan;18(4):225-261.)

Read publication

Using insulin pump with a remote-control system in young patients with diabetes improves glycemic control and enhances patient satisfaction

(Deeb et al. Clin. Diabetes Endocrinol. 2019 Jun 6;5:7.)

Read publication

Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems

(Freckmann et al. Diabetes Technol. Ther. 2019 Apr;21(4):201-208)

Read publication

Comparative Handling Analysis of Different Insulin Pump Systems

(Waldenmaier et al. J Diabetes Sci Technol. 2018 Mar;12(2):401-406)

Read publication

Concept and Implementation of a Novel Patch Pump for Insulin Delivery

(Ulbrich et al. J Diabetes Sci Technol. 2019 Aug (Epub))

Read publication

Concept and Implementation of a Novel Patch Pump for Insulin Delivery

(Ulbrich et al. J Diabetes Sci Technol. 2020 Mar;14(2):324-327.)

Read publication

Analysis of the Waste Volume and CO 2-Equivalent Caused by the Use of Selected Patch Pumps

(Winkelkötter et al. J Diabetes Sci Technol. 2021 (Epub))

Read publication

Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies

(Freckmann et al. J Diabetes Sci Technol. 2020 (Epub))

Read publication

Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents

(Ziegler et al. Pediatr. Diabetes. 2020 Jun;21(4):649-656.)

Read publication

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion

(Ziegler et al. Diabetes Technol. Ther. 2021 May;23(5):350-357.)

Read publication

Digital Solutions

Utilizing eHealth and Telemedicine Technologies to Enhance Access and Quality

(Barnard et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)

Read publication

A Digital-First Model of Diabetes Care

(Cafazzo et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821))

Read publication

Real-World Assessments of mySugr Mobile Health App

(Debong et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy

(Forlenza et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

The Emerging Role of Telemedicine and Mobile Health Technologies in Improving Diabetes Care

(Garg et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

Current Status and Future Directions for Electronic Point-of-Care Clinical Decision Support to Improve Diabetes Management in Primary Care

(O'Connor et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)

Read publication

Use of Telemedicine Technologies in Diabetes Prevention and Control in Resource-Constrained Settings - Lessons Learned from Emerging Economies

(Pradeepa et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

Virtual Coaching to Enhance Diabetes Care

(Ramchandani et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)

Read publication

Integrated Personalised Diabetes Management

Benefit of Digital Tools Used for Intergrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program

(Heinemann et al. J Diabetes Sci Technol. 2019 Aug (Epub))

Read publication

Patient-centred care in type 2 diabetes mellitus - key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report

(Fritzen et al. Diabetes Res. Clin. Pract. 2019 Dec (Epub))

Read publication

Intergrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program

(Kulzer et al. Diab. Res. Clin. Pract. 2018 Oct;144:200-2012)

Read publication

Intergrated Personalized Diabetes Management (PDM): Design of the ProValues Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.

(Kulzer et al. J Diabetes Sci Technol. 2016 May;10(3):722-781.)

Read publication

PDM-ProValue meets cardiovascular outcome trials in diabetes

(Fritzen et al. Cardiovasc. Diabetol. 2019 Jan 28;18(1):10)

Read publication

Chronic Kidney Disease

Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data

(Ravizza et al. Nat Med. 2019 Jan:25(1):57-59.)

Read publication

Other

Modeling of Diabetes and Its Clinical Impact

(Fritzen et al. Diabetes Sci Technol. 2018 Sep;12(5):976-984.)

Read publication

Diabetes management intervention studies: lessons learned from two studies

(Petersen et al. Trials, 2021 Jan 18;22(1):61.)

Read publication

Human Factors Engineering and Diabetes Technology: A Close Relationship

(Valerie Eichinger et al. Journal of Diabetes Science and Technology (EPub), August 2, 2024)

Read publication

CIPII

Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes

(Pasquini et al. Acta Diabetol. 2019 Aug 9.)

Read publication

A New Optimized Percutaneous Access System for CIPII

(Garcia-Verdugo et al. J Diabetes Sci Technol. 2019 Jul;11(4):814-821)

Read publication

Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study

(Dassau et al. Diabetes Obs. Metab. 2017 Dec;19(12):1698-1705.)

Read publication

New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion

(Rieger et al. J Diabetes Sci Technol. 2019 Jun (Epub))

Read publication

Automated Insulin Delivery

Overnight closed-loop control improves glycemic control in a multicenter study of adults with type 1 diabetes

(Brown et al. Clin. Endocrinol. Metab. 2017 Oct 1;102(10):3674-3682.)

Read publication

Twelve-week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin a1c and Hypoglycemia

(Dassau et al. Diabetes Care 2018 Dec;40(12):1719-1726.)

Read publication

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study

(Breton et al. Diabetes Care 2017 Dec;40(12):1644-1650.)

Read publication

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes

(Cameron et al. Diabetes Technol. Ther. 2017 Sep;19(9):527-532.)

Read publication

Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses

(Sanchez-Pena et al. J Diabetes Sci Technol. 2018 Sep;12(5):914-925.)

Read publication

Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp.

(Ly et al. Diabetes Care 2016 Aug;39(8):e 106-7.)

Read publication

Outpatient Closed-Loop Control With Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control

(Huyett et al. Diabetes Technol. Ther. 2017 Jun;19(6):331-339.)

Read publication

Randomized Controlled Trial of Mobile Closed-Loop Control

(Kovatchev et al. Diabetes Care 2020 Mar;43(3):607-615.)

Read publication
 

Brochures - Our Solutions

Highlights

Accu-Chek SmartGuide CGM

  • Comfortable and water-resistant Accu-Chek SmartGuide sensor 
  • Comes in a disposable, all-in-one sensor applicator for simple sensor application
  • 14-day wear time
  • Wireless data transfer to the CGM app every five minutes
View brochure

Accu-Chek SmartGuide App

  • Customisable glucose alarms, so corrective action can be taken to avoid an excursion
  • Logbook to record insulin, meals, and more
  • Graphs and statistics to help patients learn about their diabetes
View brochure

Accu-Chek SmartGuide Predict App

  • Predictive features: Low glucose predict, glucose predict, night low predict for action to avoid hypoglycaemia
  • Glucose patterns report: Insights into glucose levels and suggestions of potential causes for excursions
  • Ready-to-use PDF reports: easily exported and shared, including patient's AGP and glucose patterns
View brochure

More solution brochures

Accu-Chek Care Platform

  • All-in-one platform which enables integrated Personalised Diabetes Management (iPDM)
  • Seamless connection with 150+ diabetes management devices and mySugr patient app, encouraging diabetes self-management
  • Actionable insights for more efficient consultations
  • The Customer Population Insights Dashboard provides population health analytics for HCPs, Admins, and Payers
  • Patient tracking and therapy adjustment for personalised care
  • Under constant evolution to support you now and in the future
View brochure

mySugr app

  • More than 5.5 million registered users
  • Automated data integration of leading BG meters (e.g. Accu-Chek Guide), CGM and activity data from cloud-based integrations Apple health (Dexcom G5/G6) and Google Fit (steps)
  • mySugr PRO includes a bolus calculator in certain countries.
  • Comprehensive reports to share from the mySugr app with Healthcare Professionals
  • Integrations:
    - Accu-Chek Care Platform: Integration of BG values, carb information, CGM, and insulin data into Accu-Chek Care platform
    - Smart insulin pen integration: Integration of insulin data from the NovoPen 6 and NovoPen Echo Plus into the mySugr Logbook

View brochure

Accu-Chek Guide

  • Spill-resistant SmartPack vial:: Easy to take out one strip at a time
  • Simple to see, day or night: Bright port light and backlit display
  • Wide dosing area: Simply touch any part of the yellow edge to your blood drop.

Connects to mySugr app and Accu-Chek Care platform to enable integrated Personalised Diabetes Management (iPDM).

View brochure

Accu-Chek Guide Me

  • Large, easy-to-read display
  • Simple two-button navigation
  • Fast, easy-to-fill strip with results in less than 4 seconds

Connects to mySugr app and Accu-Chek Care platform to enable integrated Personalised Diabetes Management (iPDM).

View brochure

Accu-Chek Instant

  • Instant understanding: The target range indicator provides an instant view to see if your result is high, low, or in range
  • Easy to read: Clearly see results on the large backlit display.
  • Easy testing: Apply blood on the edge of the wide application area.
  • Clean strip disposal: Simple ejector for hygienic removal
  • Connects to mySugr app and Accu-Chek Care platform to enable integrated Personalised Diabetes Management (iPDM).
View brochure

Accu-Chek Solo

  • First detachable and tube-free insulin pump 
  • Unique quick bolus buttons on pump
  • Diabetes Manager with open bolus advice to combine therapy with continuous glucose monitoring solutions
  • Connected to the Accu-Chek Care platform, allowing the combined visualisation of insulin and blood glucose data to detect therapy patterns and improve outcomes 
View brochure

Smart Pen Integration in mySugr Logbook

  • All-in-one: Manage glucose levels, insulin, and carb data in just one app.
  • Easy: Automated logging of insulin time and dose together with glucose values
  • Multiple pen pairing: Option to connect up to 8 pens
  • Intuitive visualisation: Valuable insights on patterns and therapy effectiveness
View brochure

Visit us

We look forward to welcoming you to our booth no. B.04 and talk with you about our new Accu-Chek SmartGuide CGM solution and the power of prediction!
For those who will join the EASD conference online, please make sure to visit our virtual Showroom, where you find more information on our new Accu-Chek SmartGuide CGM solution! Feel free to contact us for more information and visit us on LinkedIn .

This website contains information on products that are targeted to a wide range of audiences and may contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information that may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

© 2024 Roche Diabetes Care. All rights reserved.